Regen BioPharma Inc (RGBP)
About Regen BioPharma Inc
REGEN BIOPHARMA INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $236.6K
- Net income
- -$1.3M
- Total assets
- $274.6K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Regen BioPharma Inc (RGBP) Stock Price
- Reported a net loss of $1.3M in FY2025.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Regen BioPharma Inc.
Write a review
News about Regen BioPharma Inc
News & sentiment via Polygon.io
Regen BioPharma Inc: frequently asked questions
Is Regen BioPharma Inc an American company?
Regen BioPharma Inc is a US-based company headquartered in La Mesa, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Regen BioPharma Inc headquartered?
Regen BioPharma Inc is headquartered in La Mesa, California, United States.
Is Regen BioPharma Inc publicly traded?
Yes — Regen BioPharma Inc is a publicly traded company. Its stock trades under the ticker symbol RGBP on the OTC.
What does Regen BioPharma Inc do?
Regen BioPharma Inc is an American Pharmaceuticals company in the Health & Beauty sector.
